← Back to Search

Lifestyle Intervention for Cancer Survivors

N/A
Recruiting
Led By Cynthia Thomson, MD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 13-weeks, and 25-weeks
Awards & highlights

Study Summary

This trial is testing an intervention to help Hispanic cancer survivors reduce symptoms and adhere to American Cancer Society guidelines for cancer prevention.

Who is the study for?
This trial is for Hispanic cancer survivors over 18 who've finished treatment within the last year, except hormonal therapy or trastuzumab. They must have a caregiver to join with them and suffer from symptoms like pain or fatigue rated at least 4 out of 10 in severity. Participants need phone access and must understand English or Spanish.Check my eligibility
What is being tested?
The study compares two approaches: one group will only assess their symptoms, while the other will also receive guidance on symptom management and lifestyle changes aimed at meeting nutrition and physical activity guidelines to improve health and reduce cancer risk.See study design
What are the potential side effects?
Since this trial involves non-medical interventions such as lifestyle modifications, side effects may include discomfort from increased physical activity or dietary changes but are generally expected to be minimal compared to drug treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 13-weeks, and 25-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 13-weeks, and 25-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline vegetable and fruit intake at 25-weeks in survivors
Change in vegetable and fruit intake at 13-weeks in survivors
Secondary outcome measures
Physical activity
Symptom severity
Vegetable and fruit intake in caregivers

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Symptom management and lifestyle interventionExperimental Treatment1 Intervention
Dyads will receive 12 weekly telephone-based coaching sessions, a participant educational handbook, and a pedometer for self-monitoring physical activity.
Group II: Attention controlActive Control1 Intervention
Dyads will receive mailed print education materials regarding healthy lifestyle (nutrition and physical activity) disseminated by ACS and NCI. They will also receive 12 weekly phone calls to assess post-treatment related symptoms.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
512 Previous Clinical Trials
147,584 Total Patients Enrolled
3 Trials studying Cancer Survivors
281 Patients Enrolled for Cancer Survivors
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,240 Total Patients Enrolled
1 Trials studying Cancer Survivors
212 Patients Enrolled for Cancer Survivors
Cynthia Thomson, MDPrincipal InvestigatorUniversity of Arizona

Media Library

Symptom management and lifestyle intervention Clinical Trial Eligibility Overview. Trial Name: NCT05364372 — N/A
Cancer Survivors Research Study Groups: Symptom management and lifestyle intervention, Attention control
Cancer Survivors Clinical Trial 2023: Symptom management and lifestyle intervention Highlights & Side Effects. Trial Name: NCT05364372 — N/A
Symptom management and lifestyle intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05364372 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this study taking place at the moment?

"Absolutely. According to information sourced from clinicaltrials.gov, this medical research project is currently enrolling participants; it was first posted on the 25th of August 2022 and has since undergone some revisions. A total of 217 patients are needed at one particular location for participation in the trial."

Answered by AI

How many individuals are eligible to take part in this clinical research initiative?

"Absolutely. According to clinicaltrials.gov, this medical investigation is actively recruiting participants as of August 25th 2022 - the same day it was posted and last updated. 217 subjects are required at a single site."

Answered by AI
~119 spots leftby Mar 2026